ARAY
Accuray Incorporated
NASDAQ: ARAY · HEALTHCARE · MEDICAL DEVICES
$3.08
-3.75% today
Updated 2026-11-12
Market cap
$16.72M
P/E ratio
—
P/S ratio
0.04x
EPS (TTM)
$-0.40
Dividend yield
—
52W range
$0 – $1
Volume
9.3M
Accuray Incorporated (ARAY) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.08
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0.4B | $0.4B | $0.4B | $0.5B | $0.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -12.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.